Surgical Management of Underlying Biliary Disease in Refractory Hyperemesis Gravidarum
Surgical Management of Underlying Biliary Disease in Refractory Hyperemesis Gravidarum
Author Info
Carolyn Chatterton Firas Bridges Jennifer McEachron Pankaj Singhal
Corresponding Author
Jennifer McEachronDivision of Gynecologic Oncology, Downstate Medical Center, University Hospital of Brooklyn, Brooklyn, NY
A B S T R A C T
Hyperemesis gravidarum (HEG) is the most common cause of hospitalization during the first half of pregnancy. It affects approximately 0.3-3% of all pregnancies [1]. There is no one accepted definition or diagnostic criteria for HEG. The most commonly cited criteria include persistent vomiting not related to other causes, measure of acute starvation (most commonly ketonuria), and weight loss; most often loss of at least 5% of pre-pregnancy body weight [2]. Symptoms typically begin in the late first trimester and are rarely associated with abdominal pain. HEG is managed a stepwise fashion by adding pharmacotherapy sequentially until symptom resolution [3, 4]. Patients who present with classic signs and symptoms of HEG but are non-responsive to all levels of therapy present a therapeutic challenge. In these cases, the search for other causes of nausea and vomiting should be undertaken.
Article Info
Article Type
Case ReportPublication history
Received: Tue 05, Nov 2019Accepted: Tue 19, Nov 2019
Published: Mon 25, Nov 2019
Copyright
© 2023 Jennifer McEachron. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.DOI: 10.31487/j.SCR.2019.06.05